Subscribe Now Subscribe Today
Research Article

Analysis of Blood for Secnidazole in Female Volunteers by HPLC Method

Suriya Bibi , Rakhshanda Nawaz , M. Nawaz , Muhammad Shahid and Sobia Qamar Kiani
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

The biokinetics parameters were investigated following oral dose of 1g secnidazole in healthy female volunteers. The plasma samples were deproteinized by ZnSO4 and NaOH analyzed by HPLC. The mean maximum concentration in plasma was found to be 23.08?0.8 after 2.5 h of drug administration. The area under curve (AUC) was 349.05 ± 20.9 h mg L-1. The clearance and volume of distribution were 0.44 ± 0.37 L h-1 and 11.09 ± 7.81 L respectively. The elimination half life was 13.86?0.92 h. The values for absorption rate constant and absorption half life were 2.97 ± 0.46 L h-1 and 0.27?0.03 h. The maximum concentration 16.24 ± 0.48 mg L-1 was achieved in 1.77 ± 0.16 h. These parameters showed that protein deproteinization method and analysis techniques are valid for the protein analysis of secnidazole.

Related Articles in ASCI
Similar Articles in this Journal
Search in Google Scholar
View Citation
Report Citation

  How to cite this article:

Suriya Bibi , Rakhshanda Nawaz , M. Nawaz , Muhammad Shahid and Sobia Qamar Kiani , 2002. Analysis of Blood for Secnidazole in Female Volunteers by HPLC Method . Journal of Biological Sciences, 2: 769-770.

DOI: 10.3923/jbs.2002.769.770


1:  Baggot, J.D., 1977. Principle of Drug Disposition in Domestic Animals. W.B. Saunders Company, Philadelphia, USA.

2:  Benazet, F. and L. Guillaume, 1976. Amoebicidal and trichomonacidal activities of secnidazole in the laboratory. Bull. Soci. Pathol. Fxotique, 69: 309-319.

3:  Gillis, J.C. and L.R. Wiseman, 1996. Secnidazole: A review of its antimicrobial activity, pharmacokinetics properties and therapeutic use in the management of protozoal infections and bacterial vagueness. Drugs, 51: 621-638.

4:  Jessa, M.J., D.A. Barrett, P.N. Shaw and R.C. Spiller, 1996. Rapid and selective high performance liquid chromatographic method for the determination of metronidazole and its active metabolite in human plasma, saliva and gastric juice. J. Chromatogr. B: Biomed. Sci. Appl., 677: 374-379.

5:  Nawaz, M., T. Iqbal and R. Nawaz, 1988. Geodetical consideration in biodisposition kinetic evaluation of chemotherapeutic agents. Cong. Europ. Assoc. Vet. Pharm. Therapy, 28th August 2nd Sept. Budapest.

6:  Nawaz, M., 1994. Geodetical factors affecting biodisposition of drugs. Canada J. Physiol. Pharmacol. Abst. pp: 12, 257 11 Int. Cong. Pharmacol., July 24-29, 1994 Monteral Canada.

7:  Rombout, F., 1987. Incorporation with university centre for pharmacy. Department of Pharmacology and Therapeutics, University of Gronigen and Medilware, Copy Right, 1987-1991.

8:  Saracoglu, F., K. Gol, I. Sahin, B. Turkisani, C. Atalay and C. Oztopcu, 1998. Treatment of bacterial vagueness with oral or vaginal ornidazole, Secnidazole and metronidazole. Int. J. Gynaecal. Abst., 62: 59-61.

9:  Sekhar, K.R., M.U.R. Naidu, E.C. Sekhar, T.R.K. Rao, J.C. Shobba, P.U. Rani and K.J. Surya, 1997. Rapid and selective analysis of secnidazole in human plasma using high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. B: Biomed. Sci. Appl., 691: 208-211.

10:  Shahid, M., 2001. Biokinetics of secnidazole in male volunteers determined by HPLC method. M.Phil. Thesis, Department of Chemistry, University of Agriculture, Faisalabad, Pakistan.

11:  Thami, G.P. and A.J. Kanwar, 1998. Fixed drug eruption due to metronidazole and tinidazole without cross-sensitivity to secnidazole. Dermatology, 196: 368-368.

12:  Tenenbaum, H., F.J. Cusinier, A. Le Liboux, E. Pichard, G. Montay and A. Frydman, 1993. Secnidazole concentration in plasma and crevicular fluid after a single oral dose. J. Clin. Periodontol., 20: 505-508.

©  2021 Science Alert. All Rights Reserved